Langenberg, Marlies H G <br/><br/>
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 2009 
 - 6152-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2009.22.2273  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antihypertensive Agents--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypertension--chemically induced<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Prospective Studies<br/>Quinazolines--adverse effects<br/>Signal Transduction--drug effects<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Young Adult